The Lancet Oncology(@TheLancetOncol) 's Twitter Profileg
The Lancet Oncology

@TheLancetOncol

The Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=51.1

ID:50265238

linkhttp://www.thelancet.com/journals/lanonc calendar_today24-06-2009 09:52:31

9,9K Tweets

57,5K Followers

421 Following

The Lancet Haematology(@TheLancetHaem) 's Twitter Profile Photo

NEW: Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) induced deep responses in transplant-eligible patients with newly diagnosed multiple myeloma in the SKylaRk phase 2 trial thelancet.com/journals/lanha…

NEW: Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) induced deep responses in transplant-eligible patients with newly diagnosed multiple myeloma in the SKylaRk phase 2 trial #mmsm thelancet.com/journals/lanha…
account_circle
Common Sense Oncology(@csoncol) 's Twitter Profile Photo

Common Sense Oncology leadership team is having its first annual meeting next week in Montreal. Our opening plenary session will be open to all CSO members. Join us by zoom for the LIVE plenary session with these leaders in our field.
Register for zoom link here-…

Common Sense Oncology leadership team is having its first annual meeting next week in Montreal. Our opening plenary session will be open to all CSO members. Join us by zoom for the LIVE plenary session with these leaders in our field. Register for zoom link here-…
account_circle
The Lancet Digital Health(@LancetDigitalH) 's Twitter Profile Photo

It's our 5th birthday! Read our Editorial for our reflections on the last five years of research. We look forward to championing equity, transparency and inclusivity in the field over next five years with our authors, reviewers and readers.

thelancet.com/journals/landi…

It's our 5th birthday! Read our Editorial for our reflections on the last five years of #DigitalHealth research. We look forward to championing equity, transparency and inclusivity in the field over next five years with our authors, reviewers and readers. thelancet.com/journals/landi…
account_circle
The Lancet Oncology(@TheLancetOncol) 's Twitter Profile Photo

Attending ? David Collingridge, Editor-in-Chief, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q01PY6L00

Attending #ESTRO2024? David Collingridge, Editor-in-Chief, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q01PY6L00
account_circle
The Lancet(@TheLancet) 's Twitter Profile Photo

There’s still time to register for this year’s @UCL Lancet Lecture on the toll of race and inequality on the health of people, which explores discriminatory practices in medical care.

Register: hubs.li/Q02thkTj0
📅 Apr 30, 17:30
📍 London & online

There’s still time to register for this year’s @UCL Lancet Lecture on the toll of race and inequality on the health of people, which explores discriminatory practices in medical care. Register: hubs.li/Q02thkTj0 📅 Apr 30, 17:30 📍 London & online
account_circle
The Lancet(@TheLancet) 's Twitter Profile Photo

Many people with breast cancer ‘systematically left behind’ due to inaction on inequities & hidden suffering, says new Lancet Commission.

Explore authors’ recommendations to address these urgent challenges in ▶️ hubs.li/Q02sX1Gs0

Many people with breast cancer ‘systematically left behind’ due to inaction on inequities & hidden suffering, says new Lancet Commission. Explore authors’ recommendations to address these urgent challenges in #BreastCancer ▶️ hubs.li/Q02sX1Gs0
account_circle